TCBP(Delisted)
TC BioPharmยทNASDAQ
--
--(--)
TCBP Profile
Tc Biopharm (Holdings) Plc.
A biotechnology company that develops immunotherapies for cancer and infectious diseases
--
10/25/2021
02/11/2022
NASDAQ Stock Exchange
41
12-31
Depository Receipts (Ordinary Shares)
Maxim 1, 2 Parklands Way, Holytown, Motherwell, ML1 4WR, Scotland, United Kingdom
--
TC BioPharm (Holdings) plc., a company incorporated under the laws of Scotland on October 25, 2021. The company is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products based on the proprietary allogeneic gamma delta T (GD-T) cell platform. Leveraging the innate capabilities of GD-Ts, the company has been able to develop a range of clinical-stage cell therapies designed to combat cancer and viral infections.
